Do newer generation drug-eluting stents with ultrathin struts improve clinical outcomes for patients undergoing percutaneous coronary intervention (PCI)? Join Ashwin Mehta, Upendra Kaul and Anirban Choudhary in a discussion about the TALENT non-inferiority trial, which compared PCI using the Supraflex sirolimus-eluting stent with ultrathin struts with the Xience everolimus-eluting stent. What are the implications of the trial for interventional cardiologists’ daily practice and what are the next steps for research into ultrathin stents? This interview supported by SMT was filmed at #EuroPCR 2019: see more videos here
0 Comments